JP Morgan Chase’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
JP Morgan Chase's NVO Position: Q2 2026 in Review
JP Morgan Chase reduced its Novo Nordisk (NVO) stake by 43% in Q2 2026, selling an estimated $51.4M and leaving 1,612,426 shares worth $77.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.
JP Morgan Chase first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $722M in Q1 2024. 1,355 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- JP Morgan Chase held 1,612,426 shares of Novo Nordisk worth $77.9M as of Q2 2026.
- JP Morgan Chase sold 1,196,392 Novo Nordisk shares in Q2 2026, an estimated $51.4M.
- Novo Nordisk made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1193 holding.
- JP Morgan Chase first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Novo Nordisk position peaked at $722M in Q1 2024.
- 1,355 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.